Treatment with human umbilical cord blood serum in a gentamicin-induced nephrotoxicity model in rats

References

• Ademiluyi, A.O., et al., 2013. Modulatory effects of dietary inclusion of garlic (Allium sativum) on gentamycin-induced hepatotoxicity and oxidative stress in rats. Asian Pacific Journal of Tropical Biomedicine, 3 (6), 470–475.
   PubMedGoogle Scholar
• Caseiro, A.R., et al., 2018. Human umbilical cord blood plasma as an alternative to animal sera for mesenchymal stromal cells in vitro expansion – a multicomponent metabolomic analysis. PLOS One, 13 (10), e0203936-e0203936.
   Web of Science ®Google Scholar
• Coimbra, T.M., Cieslinski, D.A., and Humes, H.D., 1990. Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. American Journal of Physiology-Renal Physiology, 259 (3), F438–F443.
   Google Scholar
• Dinarello, C.A., 2000. Proinflammatory cytokines. Chest, 118 (2), 503–508.
   PubMed Web of Science ®Google Scholar
• Doorn, J., et al., 2012. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Engineering Part B: Reviews, 18 (2), 101–115.
   PubMed Web of Science ®Google Scholar
• Ebrahimi, M.J., et al., 2018. Human Umbilical Cord Matrix Stem Cells Reverse Oxidative Stress-Induced Cell Death and Ameliorate Motor Function and Striatal Atrophy in Rat Model of Huntington Disease. Neurotoxicity Research, 34 (2), 273–284.
   PubMed Web of Science ®Google Scholar
• El-Kashef, D.H., et al., 2015. Protective effect of allicin against gentamicin-induced nephrotoxicity in rats. International Immunopharmacology., 29 (2), 679–686.
   PubMed Web of Science ®Google Scholar
• Fan, C.-G., Zhang, Q-j., and Zhou, J-r., 2011. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell. Stem Cell Reviews and Reports, 7 (1), 195–207.
   PubMed Web of Science ®Google Scholar
• Ferguson, M.A., Vaidya, V.S., and Bonventre, J.V., 2008. Biomarkers of nephrotoxic acute kidney injury. Toxicology, 245 (3), 182–193.
   PubMed Web of Science ®Google Scholar
• Finn, W.F., et al., 2003. Urinary biomarkers and nephrotoxicity. In: M. E. de Broe, G. A. Porter, W. M. Bennett, ed. Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals. Dordrecht: Springer Netherlands, p. 621–655.
   Google Scholar
• Gilbert, T., Lelievre-Pegorier, M., and Merlet-Benichou, C., 1991. Long-term effects of mild oligonephronia induced in utero by gentamicin in the rat. Pediatric Research, 30 (5), 450–456.
   PubMed Web of Science ®Google Scholar
• González-Ramos, R., Defrère, S., and Devoto, L., 2012. Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertility and Sterility, 98 (3), 520–528.
   PubMed Web of Science ®Google Scholar
• Huang, L., et al., 2011. Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cells. Cytotherapy, 13 (6), 712–721.
   PubMed Web of Science ®Google Scholar
• Humes, H.D., et al., 1989. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. Journal of Clinical Investigation, 84 (6), 1757–1761.
   PubMed Web of Science ®Google Scholar
• Karimi, Z., et al., 2020. Toll-like receptor-2 mediates systemic inflammation in gentamicin-induced rat nephrotoxicity. Clinical and Experimental Pharmacology and Physiology., 47 (9), 1584–1590.
   PubMed Web of Science ®Google Scholar
• Kohli, H.S., et al., 2000. Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrology Dialysis Transplantation, 15 (2), 212–217.
   PubMed Web of Science ®Google Scholar
• Kumar, P., Nagarajan, A., and Uchil, P.D., 2018. Analysis of cell viability by the lactate dehydrogenase assay. Cold Spring Harbor Protocols, 2018 (6), pdb.prot095497. 10.1101/pdb.prot095497.
   Google Scholar
• Li, P., et al., 2015. Transplantation of human umbilical cord-derived mesenchymal stems cells for the treatment of Becker muscular dystrophy in affected pedigree members. International Journal of Molecular Medicine., 35 (4), 1051–1057.
   PubMed Web of Science ®Google Scholar
• Li, P.K.T., Burdmann, E.A., and Mehta, R.L, World Kidney Day Steering C. 2013. Acute kidney injury: global health alert. Intern Med J, 43 (3), 223–226.
   PubMed Web of Science ®Google Scholar
• Lopez-Novoa, J.M., et al., 2011. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int, 79 (1), 33–45.
   PubMed Web of Science ®Google Scholar
• Mirazi, N., et al., 2021. Human umbilical cord blood serum attenuates gentamicin-induced liver toxicity by restoring peripheral oxidative damage and inflammation in rats. Basic & Clinical Pharmacology & Toxicology, 128 (2), 268–274.
   PubMed Web of Science ®Google Scholar
• Moghadasali, R., et al., 2013. Mesenchymal stem cell-conditioned medium accelerates regeneration of human renal proximal tubule epithelial cells after gentamicin toxicity. Experimental and Toxicologic Pathology., 65 (5), 595–600.
   PubMed Web of Science ®Google Scholar
• Nash, K., Hafeez, A., and Hou, S., 2002. Hospital-acquired renal insufficiency. American Journal of Kidney Diseases, 39 (5), 930–936.
   PubMed Web of Science ®Google Scholar
• Rafieian-Kopaei, M., et al., 2013. Efficacy of co-administration of garlic extract and metformin for prevention of gentamicin-renal toxicity in wistar rats: a biochemical study. Int J Prev Med, 4 (3), 258–264. eng.
   PubMedGoogle Scholar
• Rangan, G.K., and Tesch, G.H., 2007. Quantification of renal pathology by image analysis. Nephrology, 12 (6), 553–558.
   PubMed Web of Science ®Google Scholar
• Rota, C., Morigi, M., and Imberti, B., 2019. Stem Cell Therapies in Kidney Diseases: Progress and Challenges. International Journal of Molecular Sciences, 20 (11), 2790.
   PubMed Web of Science ®Google Scholar
• Shetty, P., Bharucha, K., and Tanavde, V., 2007. Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells. Cell Biology International, 31 (3), 293–298.
   PubMed Web of Science ®Google Scholar
• Tavafi, M., 2012. Inhibition of gentamicin-induced renal tubular cell necrosis. Journal of Nephropathology, 1 (2), 83–86.
   PubMedGoogle Scholar
• Tekkatte, C., et al., 2012. Enhancement of adipogenic and osteogenic differentiation of human bone-marrow-derived mesenchymal stem cells by supplementation with umbilical cord blood serum. Cell and Tissue Research, 347 (2), 383–395.
   PubMed Web of Science ®Google Scholar
• Tögel, F., et al., 2005. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. American Journal of Physiology – Renal Physiology, 289 (1), F31–F42.
   PubMed Web of Science ®Google Scholar
• Vysakh A., et al., 2018. Protective effect of Rotula aquatica Lour against gentamicin induced oxidative stress and nephrotoxicity in Wistar rats. Biomedicine & Pharmacotherapy., 106, 1188–1194.
   PubMed Web of Science ®Google Scholar
• Yao, J., et al., 2019. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. The FASEB Journal, 33 (2), 1695–1710.
   PubMed Web of Science ®Google Scholar